Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

1.

Belatacept.

Vincenti F, Dritselis A, Kirkpatrick P.

Nat Rev Drug Discov. 2011 Aug 31;10(9):655-6. doi: 10.1038/nrd3536. No abstract available.

PMID:
21878974
[PubMed - indexed for MEDLINE]
2.

Belatacept (Nulojix) for prevention of renal transplant rejection.

[No authors listed]

Med Lett Drugs Ther. 2011 Dec 12;53(1379-1380):98-9. No abstract available.

PMID:
22173428
[PubMed - indexed for MEDLINE]
3.

[Belatacept, a new original molecule, immunosuppressive, in organ transplantation].

Beaudreuil S, Durrbach A, Kriaa F, Charpentier B.

Med Sci (Paris). 2006 Apr;22(4):354-5. French. No abstract available.

PMID:
16597399
[PubMed - indexed for MEDLINE]
Free Article
4.

T-cell phenotype in protocol renal biopsy from transplant recipients treated with belatacept-mediated co-stimulatory blockade.

Grimbert P, Audard V, Diet C, Matignon M, Plonquet A, Mansour H, Desvaux D, Durrbach A, Cohen JL, Lang P.

Nephrol Dial Transplant. 2011 Mar;26(3):1087-93. doi: 10.1093/ndt/gfq453. Epub 2010 Jul 28.

PMID:
20667993
[PubMed - indexed for MEDLINE]
Free Article
5.

Assessment of belatacept-mediated costimulation blockade through evaluation of CD80/86-receptor saturation.

Latek R, Fleener C, Lamian V, Kulbokas E 3rd, Davis PM, Suchard SJ, Curran M, Vincenti F, Townsend R.

Transplantation. 2009 Mar 27;87(6):926-33. doi: 10.1097/TP.0b013e31819b5a58.

PMID:
19300198
[PubMed - indexed for MEDLINE]
6.

Belatacept in kidney transplantation.

Wojciechowski D, Vincenti F.

Curr Opin Organ Transplant. 2012 Dec;17(6):640-7. doi: 10.1097/MOT.0b013e32835a4c0d. Review.

PMID:
23044530
[PubMed - indexed for MEDLINE]
7.

Summary of the US FDA approval of belatacept.

Archdeacon P, Dixon C, Belen O, Albrecht R, Meyer J.

Am J Transplant. 2012 Mar;12(3):554-62. doi: 10.1111/j.1600-6143.2011.03976.x. Epub 2012 Feb 15.

PMID:
22335273
[PubMed - indexed for MEDLINE]
Free Article
8.

Profile of belatacept and its potential role in prevention of graft rejection following renal transplantation.

Gupta G, Womer KL.

Drug Des Devel Ther. 2010 Dec 1;4:375-82. doi: 10.2147/DDDT.S10432. Review.

PMID:
21151624
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Abatacept mechanism of action: concordance with its clinical profile.

Herrero-Beaumont G, Martínez Calatrava MJ, Castañeda S.

Reumatol Clin. 2012 Mar-Apr;8(2):78-83. doi: 10.1016/j.reuma.2011.08.002. Epub 2011 Nov 21. Review.

PMID:
22104048
[PubMed - indexed for MEDLINE]
Free Article
10.

Belatacept: a new era of immunosuppression?

El-Charabaty E, Geara AS, Ting C, El-Sayegh S, Azzi J.

Expert Rev Clin Immunol. 2012 Aug;8(6):527-36. Review.

PMID:
22992146
[PubMed - indexed for MEDLINE]
11.

Belatacept: a novel immunosuppressive agent for kidney transplant recipients.

Charpentier B.

Expert Rev Clin Immunol. 2012 Nov;8(8):719-28. doi: 10.1586/eci.12.79.

PMID:
23167683
[PubMed - indexed for MEDLINE]
12.

Belatacept: a new biologic and its role in kidney transplantation.

Su VC, Harrison J, Rogers C, Ensom MH.

Ann Pharmacother. 2012 Jan;46(1):57-67. doi: 10.1345/aph.1Q537. Epub 2012 Jan 3. Review.

PMID:
22215686
[PubMed - indexed for MEDLINE]
13.

Belatacept: in adult kidney transplant recipients.

Garnock-Jones KP.

BioDrugs. 2012 Dec 1;26(6):413-24. doi: 10.2165/11208900-000000000-00000. Review.

PMID:
22928660
[PubMed - indexed for MEDLINE]
14.

Advances in immunosuppression for kidney transplantation: new strategies for preserving kidney function and reducing cardiovascular risk.

Bestard O, Campistol JM, Morales JM, Sánchez-Fructuoso A, Cabello M, Cabello V, Pallardó LM, Grinyó JM.

Nefrologia. 2012 May 14;32(3):374-84. doi: 10.3265/Nefrologia.pre2012.Jan.11176. Epub 2012 Apr 17. Review. English, Spanish.

PMID:
22535159
[PubMed - indexed for MEDLINE]
Free Article
15.

CD80 (B7-1) and CD86 (B7-2): potential targets for immunotherapy?

van Gool SW, Barcy S, Devos S, Vandenberghe P, Ceuppens JL, Thielemans K, de Boer M.

Res Immunol. 1995 Mar-Apr;146(3):183-96. Review. No abstract available.

PMID:
8525052
[PubMed - indexed for MEDLINE]
16.

T-cell co-stimulatory blockade in transplantation: two steps forward one step back!

Riella LV, Sayegh MH.

Expert Opin Biol Ther. 2013 Nov;13(11):1557-68. doi: 10.1517/14712598.2013.845661. Epub 2013 Oct 1. Review.

PMID:
24083381
[PubMed - indexed for MEDLINE]
17.

Pharmacokinetics, pharmacodynamics, and immunogenicity of belatacept in adult kidney transplant recipients.

Shen J, Townsend R, You X, Shen Y, Zhan P, Zhou Z, Geng D, Wu D, McGirr N, Soucek K, Proszynski E, Pursley J, Masson E.

Clin Drug Investig. 2014 Feb;34(2):117-26. doi: 10.1007/s40261-013-0153-2.

PMID:
24217983
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Kidney transplant drug approved.

Traynor K.

Am J Health Syst Pharm. 2011 Aug 1;68(15):1372. doi: 10.2146/news110050. No abstract available.

PMID:
21785016
[PubMed - indexed for MEDLINE]
19.

CTLA-4Ig: uses and future directions.

Ben-Shoshan M.

Recent Pat Inflamm Allergy Drug Discov. 2009 Jun;3(2):132-42.

PMID:
19519590
[PubMed - indexed for MEDLINE]
20.

Absence of CD4CD25 regulatory T cell expansion in renal transplanted patients treated in vivo with Belatacept mediated CD28-CD80/86 blockade.

Chavez H, Beaudreuil S, Abbed K, Taoufic Y, Kriaa F, Charpentier B, Durrbach A.

Transpl Immunol. 2007 Jun;17(4):243-8. Epub 2007 Jan 24.

PMID:
17493526
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk